Relief Cardiovascular’s IVC flow modulation for HF treatment

Relief Cardiovascular is a private early-stage company founded in 2022 and focused on transcatheter implants for heart-failure congestion, especially volume-overload and diuretic-resistant disease. It is backed by cardiovascular-focused investors including Broadview Ventures, Advent Life Sciences, Good Growth Capital, and Heartwork Capital. The company’s lead product is the RELIEF System, which it…